最近，来自意大利技术研究院和圣马蒂诺医院的研究人员发现了一种名为Ziapin2的分子，它像一个精确的“光开关”，可以在视网膜中恢复对光的正常反应。这项研究发表在2025年1月11日的Nature Communications期刊上，论文标题为“A ...

Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.

For more information on Age-Related Macular Degeneration go to the NHS website. If you've had a diagnosis, in addition to ...

The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

Macular degeneration is a leading cause of vision loss for people over 50, but there are ways to help protect your eyesight.

DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...

BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced upcoming ...

These glasses allow people with macular degeneration to see complete objects by banishing pesky blind spots using dozens of ...

InMed Pharmaceuticals (INM) announced the selection of an intravitreal, IVT, formulation for INM-089 as a drug candidate to be utilized in the ...